Data Survei Desember 2011

7/24/2019 Data Survei Desember 2011

1/48

LAPORAN KEUANGAN

WORKSHOP AKREDITASI KE II

RS PKU 2, Senin - Kamis 18 - 21 Juli 211

NO KEBUTUHAN URAIAN ANGGARAN PENGELUARAN

1 Konsumsi Snack 2x@ 5000x50x!" R# 2$000$000 R# 1$%50$000

&akan2x @ 12$500x50x!" R# 5$000$000 R# $'%5$000(m) R# %$000$000 R# *$125$000

2 S+,a m+-a . ku"si &+-a 12x@10$000x!" R# /0$00

Ku"si 25x@2000x!" R# 200$00

(m) R# */0$00 R# '15$00

' ooko#i o#34 -i)i4 6+)i7+"3 R# 2$000$000 R# 2*0$00

Lain 8 )ain Konsumsi Pok-a INOS R# 2$200$000

O99ic+ Bo3 :% o"an; x 2 R# R# 20$000 R# 10$00

TOTAL R#


2/48

!OR"ULIR REKAPAN SUR#EILANS HARIAN IN!EKSI RU"AH SAKIT

RU"AH SAKIT PKU "UHA""ADI$AH $OG$AKARTA Ruan% IMC

&ulan ' Ta(u

T%l N) K" Nama Klien N) R" Umu* L'P ALKES $ANG TERPASANG ANTI&IOTIK +a

I#L +#L D+ ETT' TT #ENTI TIRAH BARING

Ps% A Ps% A Ps% A Ps% A Ps% A Da*i T%l

28 a"mo s+i"o 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 % cefotaxim24 50/0/0 L 2 18Oc

IPCN

Sam/aiT%l


3/48

()


4/48


RU"AH SAKIT PKU "UHA""ADI$AH $OG$AKARTA

T%l N) K" Nama Klien N) R" Umu* L'P ALKES $

I#L +#L

Ps% A Ps% A 27 suki3+m 5'*1


5/48

Ruan%

&ulan ' Ta(un

NG TERPASANG ANTI&IOTIK

D+ ETT' TT #ENTI TIRAH BARING

Ps% A Ps% A Ps% A Da*i T%l Sam/ai T%l

28 3 ceftriaxone,!"#$-


6/48

#%O

Oct-11

+aaan Ine.si RS

o' 29ot


7/48

!OR"ULIR REKAPAN SUR#EILANS HARIAN IN!EKSI RU"AH


NO T%l N) K" Nama Klien N) R" Umu* L'P

I#L +

Ps% A Ps%

1 26 muki"a! 510/1 5 P 2* 5

2 24 -u,a"ni 5'*00% 5* P 2 2%

3 23 so+!a"-ono '/**15 */ L 22 2*8(an

4 28 s"i samsi)a"si! 2'2*


8/48

SAKIT

Ruan%

&ulan ' T

LKES $ANG TERPASANG ANTI&IOTI

L D+ ETT' TT #ENTI TIRAH BARING

A Ps% A Ps% A Ps% A Da*i T%l

ceftriaxone

29 2 ceftriaxone

cefotaxime

31 ceftriaxone

1 3

Sam/aiT%l


9/48

M#%+#

Oct-11

+aaan ne.si RS

o'1ot

o'29 ot

o' 3* ot

o'31 ot


10/48

!OR"ULIR REKAPAN SUR#EILANS HARIAN IN!EKSI RU"AH


NO

T%l N) K" Nama Klien N) R" Umu* L'P

I#L +

Ps% A Ps%

1 23 ana" "ana 5'5


11/48

AKIT

LKES $ANG TERPASANG

L D+ ETT' TT #ENTI TIRAH BARING

A Ps% A Ps% A Ps% A Da*i T%l Sam/ai

T%l


12/48

Ruan% %##

&ulan ' Ta( Oct-11

ANTI&IOTIK +aaan Ine.si RS

ceftriaxone o' 29ot


13/48



T%l N) K" Nama Klien N) R" Umu* L'P ALKES $

I#L +#L

Ps% A Ps% A

3* ook = 5'*'%2 %2 L 2/

5 /

26 min!a"-o 1/''1< 50 L 2* 2%8(an

28 sua"ma-i 5'*200 0 L 2/ 1

24 nu" ,inin;si! 5'*00* '' P 2 2*

IPCN

()


14/48

Ruan% M./#0#

&ulan ' Oct-11

NG TERPASANG ANTI&IOT +aaan


Ps% A Ps% A Ps% A Da*i T%l

2/ 4

5 /

28 1

Sam/aiT%l


15/48

ne.si RS


16/48

!OR"ULIR REKAPAN SUR#EILANS HARIAN IN!EKSI RU"AH SA


T%l N) K" ama Klie N) R" Umu* L'P ALKES $

I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


17/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


18/48

ne.si RS


19/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


20/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


21/48

ne.si RS


22/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


23/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


24/48

ne.si RS


25/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


26/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


27/48

ne.si RS


28/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


29/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


30/48

ne.si RS


31/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


32/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


33/48

ne.si RS


34/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


35/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


36/48

ne.si RS


37/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


38/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


39/48

ne.si RS


40/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


41/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


42/48

ne.si RS


43/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


44/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


45/48

ne.si RS


46/48




I#L +#L

Ps% A Ps% A

28 a"mo s+ 5'*22' / ! L 2/ 1

2 sui=3o 2''1 ** ! L 2 %

24 50/0/0 L 2 18Oc

IPCN

()


47/48

IT

Ruan% IMC

&ulan ' Oct-11




cefotaxim

Sam/aiT%l


48/48

ne.si RS

Data Survei Desember 2011

Documents

Transcript of Data Survei Desember 2011